Balyasny Asset Management LLC Cytokinetics Inc Call Options Transaction History

Balyasny Asset Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$51.22 - $60.16 $10.1 Million - $11.8 Million	-196,400 Reduced 97.66%	4,700 $248,000
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $2.39 Million - $3.75 Million	-50,000 Reduced 19.91%	201,100 $10.9 Million
Q1 2024 May 13, 2024	SELL	$63.75 - $108.06 $5.67 Million - $9.62 Million	-89,000 Reduced 26.17%	251,100 $17.6 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $7.92 Million - $24.6 Million	294,800 Added 650.77%	340,100 $28.4 Million
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $1.33 Million - $1.66 Million	45,300 New	45,300 $1.33 Million
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $610,400 - $1.14 Million	-40,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$20.58 - $28.96 $823,199 - $1.16 Million	40,000 New	40,000 $866,000

407

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.31B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.